DEF 14AThe Ballot
Spyre Therapeutics, Inc. files DEF 14A
Filed Oct 27, 2023 · 2y ago · Accession 0001193125-23-264329
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Spyre Therapeutics, Inc.
- Ticker
- SYRE
- CIK
- 1636282
- Form type
- DEF 14A
- Filing date
- Oct 27, 2023
- Report date
- Nov 21, 2023
- Document
- d520772ddef14a.htm
- Size
- 1.8 MB